Health Catalyst

Health Catalyst Gross Margin

The Gross Margin of Health Catalyst (HCAT) as of Oct 10, 2026 is 33.47 %. In the previous year, Gross Margin was 45.92 % — a change of -27.11% (lower).

Gross Margin

33.47 %

YoY

-27.11%

Last updated:

Gross Margin of Health Catalyst is 2025 33.47 % . Gross Margin of Health Catalyst was 2024 45.92 % . It decreases by -27.11% lower compared to the previous year.

Health Catalyst's gross margin stands at 36.3%, down from 52.3% several years earlier.

The Health Catalyst Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
46.83 USD
Jan 1, 2019
51.37 USD
Jan 1, 2020
48.06 USD
Jan 1, 2021
48.60 USD
Jan 1, 2022
48.21 USD
Jan 1, 2023
44.55 USD
Jan 1, 2024
45.92 USD
Jan 1, 2025
33.47 USD
The Health Catalyst Gross Margin history
YEARGross MarginYoY
33.47 %-27.11%
45.92 %+3.08%
44.55 %-7.61%
48.21 %-0.79%
48.60 %+1.11%
48.06 %-6.44%
51.37 %+9.69%
46.83 %+16.26%
40.28 %—
Access this data via the Eulerpool API

Health Catalyst Stock analysis

What does Health Catalyst do? Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years. Health Catalyst is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Health Catalyst stock

Gross Margin of Health Catalyst is 33.47 % in 2025.

Gross Margin of Health Catalyst changed from 45.92 % to 33.47 %, representing a -27.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Health Catalyst since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Health Catalyst with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Health Catalyst

All Key Metrics — Health Catalyst